Our study demonstrates that TEO alleviates key hallmarks of ovalbumin-induced AD-like dermatitis in mice—including chronic pruritus, epidermal hyperplasia, cutaneous dysbiosis, and inflammatory infiltration—through the modulation of IL-4-mediated JAK/STAT signaling. The gene discussed is IL4; the disease is dermatitis.